Legal & General Group’s ARS Pharmaceuticals SPRY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$385K	Sell	47,885 -10,483	-18%	-$100K	﹤0.01%	2430
2025 Q4	$680K	Buy	58,368 +3,125	+6%	+$30.4K	﹤0.01%	2332
2025 Q3	$555K	Buy	55,243 +418	+0.8%	+$6K	﹤0.01%	2423
2025 Q2	$957K	Buy	54,825 +19,484	+55%	+$281K	﹤0.01%	2256
2025 Q1	$445K	Sell	35,341 -70	-0.2%	-$842	﹤0.01%	2434
2024 Q4	$374K	Buy	35,411 +1,489	+4%	+$20.9K	﹤0.01%	2560
2024 Q3	$492K	Buy	33,922 +2,715	+9%	+$32.3K	﹤0.01%	2463
2024 Q2	$266K	Buy	31,207 +3,550	+13%	+$31.5K	﹤0.01%	2629
2024 Q1	$283K	Sell	27,657 -500	-2%	-$3.73K	﹤0.01%	2621
2023 Q4	$154K	Hold	28,157	–	–	﹤0.01%	2735
2023 Q3	$106K	Buy	28,157 +3,178	+13%	+$20.9K	﹤0.01%	2822
2023 Q2	$167K	Sell	24,979 -39,564	-61%	-$264K	﹤0.01%	2770
2023 Q1	$420K	Buy	+64,543	New	+$496K	﹤0.01%	2366
2022 Q2	–	Sell	-1,642	Closed	-$6K	–	3647
2022 Q1	$6K	Hold	1,642	–	–	﹤0.01%	3493
2021 Q4	$11K	Sell	1,642 -2,069	-56%	-$16.8K	﹤0.01%	3444
2021 Q3	$37K	Buy	3,711 +2,668	+256%	+$65.8K	﹤0.01%	3063
2021 Q2	$32K	Sell	1,043 -265	-20%	-$8.5K	﹤0.01%	3116
2021 Q1	$57K	Buy	1,308 +1,295	+9,962%	+$61.3K	﹤0.01%	2784
2020 Q4	$1K	Buy	+13	New	+$434	﹤0.01%	3478